Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Gross Profit (2017 - 2020)

Ironwood Pharmaceuticals' Gross Profit history spans 7 years, with the latest figure at $115.8 million for Q4 2020.

  • For Q4 2020, Gross Profit changed 0.43% year-over-year to $115.8 million; the TTM value through Dec 2020 reached $386.4 million, up 26.36%, while the annual FY2020 figure was $386.4 million, 4.49% down from the prior year.
  • Gross Profit for Q4 2020 was $115.8 million at Ironwood Pharmaceuticals, up from $103.5 million in the prior quarter.
  • Across five years, Gross Profit topped out at $115.8 million in Q4 2020 and bottomed at $31.9 million in Q3 2019.
  • The 4-year median for Gross Profit is $79.2 million (2017), against an average of $79.9 million.
  • The largest annual shift saw Gross Profit plummeted 41.68% in 2019 before it surged 224.41% in 2020.
  • A 4-year view of Gross Profit shows it stood at $85.2 million in 2017, then grew by 28.17% to $109.2 million in 2018, then increased by 5.55% to $115.3 million in 2019, then rose by 0.43% to $115.8 million in 2020.
  • Per Business Quant, the three most recent readings for IRWD's Gross Profit are $115.8 million (Q4 2020), $103.5 million (Q3 2020), and $89.4 million (Q2 2020).